DERM

Journey Medical CorpCIK 1867066 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for DERM PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for DERM

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Smith Justin Adam	Director	10	$202.4K	$0	2026-07-01
Toledano Miranda Jayne	Director	8	$0	$0	2026-07-01
Herskowitz Neil	Director	8	$0	$0	2026-07-01
ROSENWALD LINDSAY A MD	Director	8	$321.4K	$0	2026-06-25
Pearce Michael Cooper	Director	4	$0	$0	2026-06-25
Alloush Ramsey	Chief Operating Officer	5	$0	$19.5K	2026-04-22
Maraoui Claude	President & CEO	22	$100.4K	$938.3K	2026-04-22
Benesch Joseph	See Remarks	13	$0	$118.3K	2026-04-22
Paley Jeffrey	Director	8	$133.8K	$17.9K	2023-11-28
Fortress Biotech, Inc.	10% Owner	5	$0	$0	2023-05-12
De Paolantonio Ernest Robert	See Remarks	4	$0	$48.6K	2022-10-04
ELI LILLY & Co	10% Owner	1	$767.36M	$0	2020-02-20
Aurora Daljit Singh	Chief Scientific Affairs Off	16	$0	$0	2020-02-20
Horan Christopher	Chief Technical Ops Officer	12	$0	$0	2020-02-20
Lyons-Williams Lori	Chief Commercial Officer	22	$0	$0	2020-02-20
Sebelius Kathleen	Director	19	$0	$0	2020-02-20
Pena Luis C.	EVP Product Development	69	$0	$794.8K	2020-02-20
Griffith Christopher M.	VP Corp. Dev. & Strategy	134	$0	$1.09M	2020-02-20
Gilbert Halley E	Director	2	$0	$0	2020-02-20
Nunn Jason Raleigh	Director	20	$0	$0	2020-02-20
Fust Matthew K	Director	27	$100.6K	$188.6K	2020-02-20
Cohen David E	Director	30	$0	$125.7K	2020-02-20
MCDADE MARK	Director	21	$0	$0	2020-02-20
RINGO WILLIAM R	Director	54	$0	$165.7K	2020-02-20
GUGGENHIME ANDREW	COO and CFO	73	$0	$1.98M	2020-02-20
BAUER EUGENE A	Chief Medical Officer	115	$0	$3.09M	2020-02-20
WIGGANS THOMAS G	CEO & Chairman of the Board	139	$679.5K	$6.01M	2020-02-20
CRAVES FRED B	Director, 10% Owner	34	$1.80M	$0	2020-02-20
Canaan Partners VIII LLC	Director, 10% Owner	2	$0	$0	2015-11-30
Hutton Wende S	Director	6	$788.4K	$0	2015-06-11
Viswanathan Ravi	10% Owner	5	$1.11M	$0	2014-10-08
NEW ENTERPRISE ASSOCIATES 13 LP	10% Owner	5	$1.11M	$0	2014-10-08
Canaan VIII LP	Director, 10% Owner	5	$788.4K	$0	2014-10-08
Bay City Capital Fund V, L.P.	10% Owner	10	$1.11M	$0	2014-10-08
Weller Harry R	10% Owner	5	$1.11M	$0	2014-10-08
DRANT RYAN D	10% Owner	5	$1.11M	$0	2014-10-08
BASKETT FOREST	10% Owner	5	$1.11M	$0	2014-10-08
KOLLURI KRISHNA KITTU	10% Owner	5	$1.11M	$0	2014-10-08
SANDELL SCOTT D	10% Owner	5	$1.11M	$0	2014-10-08
KERINS PATRICK J	10% Owner	5	$1.11M	$0	2014-10-08
MOTT DAVID M	10% Owner	5	$1.11M	$0	2014-10-08
BARRETT M JAMES	10% Owner	5	$1.11M	$0	2014-10-08
BARRIS PETER J	10% Owner	5	$1.11M	$0	2014-10-08

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Herskowitz Neil	Director	A Award	2026-07-01	2026-07-02	50,000	—	$0	168,618	SEC↗
Smith Justin Adam	Director	A Award	2026-07-01	2026-07-02	50,000	—	$0	231,618	SEC↗
Toledano Miranda Jayne	Director	A Award	2026-07-01	2026-07-02	50,000	—	$0	168,618	SEC↗
ROSENWALD LINDSAY A MD	Director	A Award	2026-06-25	2026-06-26	10,000	—	$0	221,146	SEC↗
Pearce Michael Cooper	Director	A Award	2026-06-25	2026-06-26	10,000	—	$0	67,173	SEC↗
Herskowitz Neil	Director	A Award	2026-06-25	2026-06-26	10,000	—	$0	118,618	SEC↗
Smith Justin Adam	Director	A Award	2026-06-25	2026-06-26	10,000	—	$0	181,618	SEC↗
Toledano Miranda Jayne	Director	A Award	2026-06-25	2026-06-29	10,000	—	$0	118,618	SEC↗
Maraoui Claude	President & CEO	A Award deriv	2026-04-22	2026-04-24	82,915	—	$0	82,915	SEC↗
Benesch Joseph	CFO	A Award deriv	2026-04-22	2026-04-24	41,860	—	$0	41,860	SEC↗
Alloush Ramsey	Chief Operating Officer	A Award deriv	2026-04-22	2026-04-24	62,795	—	$0	62,795	SEC↗
Maraoui Claude	President & CEO	A Award	2026-04-22	2026-04-24	49,277	—	$0	2,435,990	SEC↗
Benesch Joseph	CFO	A Award	2026-04-22	2026-04-24	28,907	—	$0	261,371	SEC↗
Alloush Ramsey	Chief Operating Officer	A Award	2026-04-22	2026-04-24	46,863	—	$0	598,543	SEC↗
Maraoui Claude	President & CEO	M Exercise deriv	2025-08-25	2025-08-26	1,250,000	—	$0	0	SEC↗
Maraoui Claude	President & CEO	F Tax w/h	2025-08-25	2025-08-26	10,877	$7.47	$81.3K	2,386,713	SEC↗
Maraoui Claude	President & CEO	M Exercise	2025-08-25	2025-08-26	1,250,000	$0.07	$87.5K	2,397,590	SEC↗
Herskowitz Neil	Director	A Award	2025-08-05	2025-08-07	20,000	—	$0	108,618	SEC↗
Pearce Michael Cooper	Director	A Award	2025-08-05	2025-08-07	20,000	—	$0	57,173	SEC↗
Toledano Miranda Jayne	Director	A Award	2025-08-05	2025-08-07	20,000	—	$0	108,618	SEC↗
Smith Justin Adam	Director	A Award	2025-08-05	2025-08-07	20,000	—	$0	171,618	SEC↗
ROSENWALD LINDSAY A MD	Director	A Award	2025-08-05	2025-08-07	50,000	—	$0	211,146	SEC↗
Herskowitz Neil	Director	A Award	2025-06-25	2025-07-07	7,173	—	$0	88,618	SEC↗
Smith Justin Adam	Director	A Award	2025-06-25	2025-07-07	7,173	—	$0	151,618	SEC↗
Pearce Michael Cooper	Director	A Award	2025-06-25	2025-07-07	7,173	—	$0	37,173	SEC↗
ROSENWALD LINDSAY A MD	Director	A Award	2025-06-25	2025-07-07	7,173	—	$0	161,146	SEC↗
Toledano Miranda Jayne	Director	A Award	2025-06-25	2025-07-07	7,173	—	$0	88,618	SEC↗
Maraoui Claude	President & CEO	A Award deriv	2025-06-17	2025-06-20	82,915	—	$0	82,915	SEC↗
Benesch Joseph	CFO	A Award deriv	2025-06-17	2025-06-20	41,860	—	$0	41,860	SEC↗
Alloush Ramsey	Chief Operating Officer	A Award deriv	2025-06-17	2025-06-20	62,795	—	$0	62,795	SEC↗
Maraoui Claude	President & CEO	A Award	2025-06-17	2025-06-20	49,277	—	$0	2,397,590	SEC↗
Benesch Joseph	CFO	A Award	2025-06-17	2025-06-20	28,907	—	$0	232,464	SEC↗
Alloush Ramsey	Chief Operating Officer	A Award	2025-06-17	2025-06-20	46,863	—	$0	551,680	SEC↗
Alloush Ramsey	COO	S Sale	2025-05-02	2025-05-05	2,857	$6.84	$19.5K	504,817	SEC↗
Benesch Joseph	CFO	S Sale	2025-05-02	2025-05-05	2,409	$6.84	$16.5K	203,557	SEC↗
Maraoui Claude	President & CEO	S Sale	2025-05-02	2025-05-05	4,834	$6.84	$33.1K	2,348,313	SEC↗
Maraoui Claude	President & CEO	S Sale	2025-03-11	2025-03-11	49,271	$5.01	$246.8K	2,003,147	SEC↗
Maraoui Claude	President & CEO	S Sale	2025-03-07	2025-03-10	14,905	$5.01	$74.7K	2,052,418	SEC↗
Maraoui Claude	President & CEO	S Sale	2025-03-06	2025-03-10	25,551	$5.04	$128.8K	2,067,323	SEC↗
Maraoui Claude	President & CEO	S Sale	2025-03-05	2025-03-05	18,147	$5.13	$93.1K	2,092,874	SEC↗
Maraoui Claude	President & CEO	S Sale	2025-03-04	2025-03-05	28,901	$5.04	$145.7K	2,111,021	SEC↗
Maraoui Claude	President & CEO	S Sale	2025-03-03	2025-03-05	23,508	$5.19	$122.0K	2,139,922	SEC↗
Benesch Joseph	CFO	S Sale	2025-02-21	2025-02-24	1,365	$5.19	$7.1K	45,966	SEC↗
Benesch Joseph	CFO	S Sale	2024-08-01	2024-08-01	9,324	$5.47	$51.0K	47,331	SEC↗
Benesch Joseph	CFO	S Sale	2024-07-23	2024-07-23	4,055	$5.40	$21.9K	56,655	SEC↗
Pearce Michael Cooper	Director	A Award	2024-07-19	2024-07-23	30,000	—	$0	30,000	SEC↗
ROSENWALD LINDSAY A MD	Director	A Award	2024-07-08	2024-07-10	9,728	—	$0	153,973	SEC↗
Toledano Miranda Jayne	Director	A Award	2024-07-08	2024-07-10	9,728	—	$0	81,445	SEC↗
Herskowitz Neil	Director	A Award	2024-07-08	2024-07-10	9,728	—	$0	81,445	SEC↗
Smith Justin Adam	Director	A Award	2024-07-08	2024-07-10	9,728	—	$0	144,445	SEC↗
Benesch Joseph	CFO	A Award	2024-05-01	2025-04-16	80,000	—	$0	205,966	SEC↗
Maraoui Claude	President & CEO	A Award	2024-05-01	2025-04-16	175,000	—	$0	2,353,147	SEC↗
ROSENWALD LINDSAY A MD	Director	P Buy	2024-03-25	2024-03-27	10,000	$3.04	$30.4K	144,245	SEC↗
ROSENWALD LINDSAY A MD	Director	P Buy	2024-03-22	2024-03-25	20,000	$3.40	$68.0K	134,245	SEC↗
Smith Justin Adam	Director	P Buy	2024-03-22	2024-03-25	30,000	$3.47	$104.1K	134,717	SEC↗
Maraoui Claude	President & CEO	P Buy	2024-03-22	2024-03-25	10,000	$3.48	$34.8K	2,163,430	SEC↗
Benesch Joseph	Interim CFO	S Sale	2024-02-22	2024-02-23	2,450	$3.75	$9.2K	60,710	SEC↗
Benesch Joseph	CFO	A Award	2024-01-03	2025-04-16	80,000	—	$0	125,966	SEC↗
Maraoui Claude	President & CEO	A Award	2024-01-03	2025-04-16	175,000	—	$0	2,178,147	SEC↗
Paley Jeffrey	Director	S Sale	2023-11-28	2023-11-29	1,745	$5.22	$9.1K	70,727	SEC↗
Paley Jeffrey	Director	S Sale	2023-11-08	2023-12-08	255	$3.76	$959	114,217	SEC↗
Paley Jeffrey	Director	S Sale	2023-11-07	2023-12-08	2,245	$3.48	$7.8K	114,472	SEC↗
Smith Justin Adam	Director	P Buy	2023-10-13	2023-10-17	33,000	$2.98	$98.3K	104,717	SEC↗
Paley Jeffrey	Director	P Buy	2023-10-06	2023-10-10	15,000	$2.98	$44.7K	72,472	SEC↗
Paley Jeffrey	Director	P Buy	2023-09-21	2023-09-25	30,000	$2.97	$89.1K	57,472	SEC↗
ROSENWALD LINDSAY A MD	Director	P Buy	2023-09-06	2023-09-08	100,000	$2.23	$223.0K	114,245	SEC↗
Maraoui Claude	President & CEO	P Buy	2023-09-06	2023-09-08	26,044	$2.52	$65.6K	2,153,430	SEC↗
Benesch Joseph	See Remarks	S Sale	2023-07-24	2023-07-25	4,072	$1.76	$7.2K	63,160	SEC↗
Maraoui Claude	President & CEO	S Sale	2023-07-24	2023-07-25	20,767	$1.76	$36.5K	2,127,386	SEC↗
Toledano Miranda Jayne	Director	A Award	2023-07-21	2023-07-25	27,472	—	$0	71,717	SEC↗
Smith Justin Adam	Director	A Award	2023-07-21	2023-07-25	27,472	—	$0	71,717	SEC↗
Paley Jeffrey	Director	A Award	2023-07-21	2023-07-25	27,472	—	$0	71,717	SEC↗
Herskowitz Neil	Director	A Award	2023-07-21	2023-07-25	27,472	—	$0	71,717	SEC↗
Maraoui Claude	President & CEO	S Sale	2023-05-17	2023-05-18	24,377	$1.34	$32.7K	2,148,153	SEC↗
Maraoui Claude	President & CEO	S Sale	2023-05-16	2023-05-18	20,000	$1.25	$25.0K	2,172,530	SEC↗
Fortress Biotech, Inc.	10% Owner	J Other	2023-05-12	2024-05-31	50,000	—	$0	3,860,467	SEC↗
Benesch Joseph	Interim CFO	S Sale	2023-02-22	2023-02-23	2,768	$1.97	$5.5K	67,232	SEC↗
Fortress Biotech, Inc.	10% Owner	J Other	2023-02-12	2024-05-31	50,000	—	$0	3,910,467	SEC↗
Fortress Biotech, Inc.	10% Owner	J Other	2022-11-12	2024-05-31	50,000	—	$0	3,960,467	SEC↗
De Paolantonio Ernest Robert	See Remarks	S Sale	2022-10-04	2023-03-01	10,093	$2.41	$24.3K	259,907	SEC↗
De Paolantonio Ernest Robert	Chief Financial Officer	S Sale	2022-10-04	2022-10-06	10,093	$2.41	$24.3K	259,907	SEC↗
Fortress Biotech, Inc.	10% Owner	J Other	2022-08-12	2024-05-31	50,000	—	$0	4,010,467	SEC↗
De Paolantonio Ernest Robert	Chief Financial Officer	A Award	2022-07-21	2022-07-25	150,000	—	$0	270,000	SEC↗
Maraoui Claude	President & CEO	A Award	2022-07-21	2022-07-25	300,000	—	$0	2,192,530	SEC↗
Toledano Miranda Jayne	Director	A Award	2022-07-21	2022-07-25	14,245	—	$0	44,245	SEC↗
Herskowitz Neil	Director	A Award	2022-07-21	2022-07-25	14,245	—	$0	44,245	SEC↗
Paley Jeffrey	Director	A Award	2022-07-21	2022-07-25	14,245	—	$0	44,245	SEC↗
Smith Justin Adam	Director	A Award	2022-07-21	2022-07-25	14,245	—	$0	44,245	SEC↗
ROSENWALD LINDSAY A MD	Director	A Award	2022-07-21	2022-07-25	14,245	—	$0	14,245	SEC↗
Fortress Biotech, Inc.	10% Owner	J Other	2022-05-12	2024-05-31	50,000	—	$0	4,060,467	SEC↗
De Paolantonio Ernest Robert	Chief Financial Officer	A Award	2022-01-14	2022-04-04	120,000	—	$0	120,000	SEC↗
Herskowitz Neil	Director	A Award	2022-01-14	2022-04-04	30,000	—	$0	30,000	SEC↗
Smith Justin Adam	Director	A Award	2022-01-14	2022-04-04	30,000	—	$0	30,000	SEC↗
Paley Jeffrey	Director	A Award	2022-01-14	2022-04-04	30,000	—	$0	30,000	SEC↗
Toledano Miranda Jayne	Director	A Award	2022-01-14	2022-04-04	30,000	—	$0	30,000	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	33,224	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	2,814	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	2,100	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	25,000	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	937	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	65,000	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	48,130	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	8,000	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	18,750	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	21,560	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	46,371	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	20,869	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	719	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	15,000	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer deriv	2020-02-20	2020-02-24	87,990	—	$0	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer deriv	2020-02-20	2020-02-24	6,378	—	$0	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer deriv	2020-02-20	2020-02-24	25,000	—	$0	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer deriv	2020-02-20	2020-02-24	15,000	—	$0	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer deriv	2020-02-20	2020-02-24	2,437	—	$0	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer deriv	2020-02-20	2020-02-24	88,251	—	$0	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer deriv	2020-02-20	2020-02-24	32,506	—	$0	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer deriv	2020-02-20	2020-02-24	71,397	—	$0	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer deriv	2020-02-20	2020-02-24	17,062	—	$0	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer deriv	2020-02-20	2020-02-24	50,178	—	$0	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer deriv	2020-02-20	2020-02-24	60,000	—	$0	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer deriv	2020-02-20	2020-02-24	10,000	—	$0	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer deriv	2020-02-20	2020-02-24	65,000	—	$0	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer deriv	2020-02-20	2020-02-24	63,750	—	$0	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer deriv	2020-02-20	2020-02-24	48,750	—	$0	0	SEC↗
Cohen David E	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
Cohen David E	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
Cohen David E	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
Cohen David E	Director	D To issuer deriv	2020-02-20	2020-02-24	10,344	—	$0	0	SEC↗
Cohen David E	Director	D To issuer deriv	2020-02-20	2020-02-24	10,344	—	$0	0	SEC↗
Cohen David E	Director	D To issuer deriv	2020-02-20	2020-02-24	14,224	—	$0	0	SEC↗
Cohen David E	Director	D To issuer deriv	2020-02-20	2020-02-24	8,620	—	$0	0	SEC↗
Cohen David E	Director	D To issuer deriv	2020-02-20	2020-02-24	17,241	—	$0	0	SEC↗
Cohen David E	Director	D To issuer deriv	2020-02-20	2020-02-24	3,000	—	$0	0	SEC↗
Sebelius Kathleen	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
Sebelius Kathleen	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
Sebelius Kathleen	Director	D To issuer deriv	2020-02-20	2020-02-24	6,896	—	$0	0	SEC↗
Sebelius Kathleen	Director	D To issuer deriv	2020-02-20	2020-02-24	20,689	—	$0	0	SEC↗
Sebelius Kathleen	Director	D To issuer deriv	2020-02-20	2020-02-24	3,000	—	$0	0	SEC↗
Sebelius Kathleen	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	D To issuer deriv	2020-02-20	2020-02-24	150,000	—	$0	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	D To issuer deriv	2020-02-20	2020-02-24	180,000	—	$0	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	D To issuer deriv	2020-02-20	2020-02-24	180,000	—	$0	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	D To issuer deriv	2020-02-20	2020-02-24	355,170	—	$0	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	D To issuer deriv	2020-02-20	2020-02-24	98,430	—	$0	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	D To issuer deriv	2020-02-20	2020-02-24	64,327	—	$0	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	D To issuer deriv	2020-02-20	2020-02-24	300,000	—	$0	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	D To issuer deriv	2020-02-20	2020-02-24	9,000	—	$0	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	D To issuer deriv	2020-02-20	2020-02-24	15,000	—	$0	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	D To issuer deriv	2020-02-20	2020-02-24	50,000	—	$0	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	D To issuer deriv	2020-02-20	2020-02-24	115,022	—	$0	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	D To issuer deriv	2020-02-20	2020-02-24	164,642	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2020-02-20	2020-02-24	3,000	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2020-02-20	2020-02-24	18,275	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2020-02-20	2020-02-24	8,620	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2020-02-20	2020-02-24	10,344	—	$0	0	SEC↗
RINGO WILLIAM R	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
Gilbert Halley E	Director	D To issuer deriv	2020-02-20	2020-02-24	20,000	—	$0	0	SEC↗
CRAVES FRED B	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
CRAVES FRED B	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
CRAVES FRED B	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
CRAVES FRED B	Director	D To issuer deriv	2020-02-20	2020-02-24	3,000	—	$0	0	SEC↗
CRAVES FRED B	Director	D To issuer deriv	2020-02-20	2020-02-24	10,334	—	$0	0	SEC↗
CRAVES FRED B	Director	D To issuer deriv	2020-02-20	2020-02-24	10,344	—	$0	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	D To issuer deriv	2020-02-20	2020-02-24	2,437	—	$0	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	D To issuer deriv	2020-02-20	2020-02-24	16,332	—	$0	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	D To issuer deriv	2020-02-20	2020-02-24	103,258	—	$0	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	D To issuer deriv	2020-02-20	2020-02-24	65,000	—	$0	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	D To issuer deriv	2020-02-20	2020-02-24	57,000	—	$0	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	D To issuer deriv	2020-02-20	2020-02-24	32,758	—	$0	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	D To issuer deriv	2020-02-20	2020-02-24	110,434	—	$0	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	D To issuer deriv	2020-02-20	2020-02-24	15,000	—	$0	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	D To issuer deriv	2020-02-20	2020-02-24	5,700	—	$0	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	D To issuer deriv	2020-02-20	2020-02-24	9,528	—	$0	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	D To issuer deriv	2020-02-20	2020-02-24	52,500	—	$0	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	D To issuer deriv	2020-02-20	2020-02-24	48,750	—	$0	0	SEC↗
Horan Christopher	Chief Technical Ops Officer	D To issuer deriv	2020-02-20	2020-02-24	140,000	—	$0	0	SEC↗
Horan Christopher	Chief Technical Ops Officer	D To issuer deriv	2020-02-20	2020-02-24	65,000	—	$0	0	SEC↗
Horan Christopher	Chief Technical Ops Officer	D To issuer deriv	2020-02-20	2020-02-24	53,333	—	$0	0	SEC↗
Horan Christopher	Chief Technical Ops Officer	D To issuer deriv	2020-02-20	2020-02-24	15,000	—	$0	0	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	D To issuer deriv	2020-02-20	2020-02-24	7,040	—	$0	0	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	D To issuer deriv	2020-02-20	2020-02-24	708	—	$0	0	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	D To issuer deriv	2020-02-20	2020-02-24	67,500	—	$0	0	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	D To issuer deriv	2020-02-20	2020-02-24	2,814	—	$0	0	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	D To issuer deriv	2020-02-20	2020-02-24	574	—	$0	0	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	D To issuer deriv	2020-02-20	2020-02-24	6,250	—	$0	0	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	D To issuer deriv	2020-02-20	2020-02-24	28,000	—	$0	0	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	D To issuer deriv	2020-02-20	2020-02-24	50,000	—	$0	0	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	D To issuer deriv	2020-02-20	2020-02-24	10,000	—	$0	0	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	D To issuer deriv	2020-02-20	2020-02-24	22,500	—	$0	0	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	D To issuer deriv	2020-02-20	2020-02-24	11,500	—	$0	0	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	D To issuer deriv	2020-02-20	2020-02-24	28,130	—	$0	0	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
Lyons-Williams Lori	Chief Commercial Officer	D To issuer deriv	2020-02-20	2020-02-24	100,000	—	$0	0	SEC↗
Lyons-Williams Lori	Chief Commercial Officer	D To issuer deriv	2020-02-20	2020-02-24	6,378	—	$0	0	SEC↗
Lyons-Williams Lori	Chief Commercial Officer	D To issuer deriv	2020-02-20	2020-02-24	65,000	—	$0	0	SEC↗
Lyons-Williams Lori	Chief Commercial Officer	D To issuer deriv	2020-02-20	2020-02-24	63,750	—	$0	0	SEC↗
Lyons-Williams Lori	Chief Commercial Officer	D To issuer deriv	2020-02-20	2020-02-24	15,000	—	$0	0	SEC↗
Lyons-Williams Lori	Chief Commercial Officer	D To issuer deriv	2020-02-20	2020-02-24	30,000	—	$0	0	SEC↗
Fust Matthew K	Director	D To issuer deriv	2020-02-20	2020-02-24	14,224	—	$0	0	SEC↗
Fust Matthew K	Director	D To issuer deriv	2020-02-20	2020-02-24	10,344	—	$0	0	SEC↗
Fust Matthew K	Director	D To issuer deriv	2020-02-20	2020-02-24	10,344	—	$0	0	SEC↗
Fust Matthew K	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
Fust Matthew K	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
Fust Matthew K	Director	D To issuer deriv	2020-02-20	2020-02-24	3,000	—	$0	0	SEC↗
Fust Matthew K	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
MCDADE MARK	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
MCDADE MARK	Director	D To issuer deriv	2020-02-20	2020-02-24	23,275	—	$0	0	SEC↗
MCDADE MARK	Director	D To issuer deriv	2020-02-20	2020-02-24	3,000	—	$0	0	SEC↗
MCDADE MARK	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
MCDADE MARK	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
MCDADE MARK	Director	D To issuer deriv	2020-02-20	2020-02-24	10,344	—	$0	0	SEC↗
MCDADE MARK	Director	D To issuer deriv	2020-02-20	2020-02-24	7,758	—	$0	0	SEC↗
GUGGENHIME ANDREW	CFO	D To issuer deriv	2020-02-20	2020-02-24	73,287	—	$0	0	SEC↗
GUGGENHIME ANDREW	CFO	D To issuer deriv	2020-02-20	2020-02-24	121	—	$0	0	SEC↗
GUGGENHIME ANDREW	CFO	D To issuer deriv	2020-02-20	2020-02-24	67,240	—	$0	0	SEC↗
GUGGENHIME ANDREW	CFO	D To issuer deriv	2020-02-20	2020-02-24	71,250	—	$0	0	SEC↗
GUGGENHIME ANDREW	CFO	D To issuer deriv	2020-02-20	2020-02-24	71,250	—	$0	0	SEC↗
GUGGENHIME ANDREW	CFO	D To issuer deriv	2020-02-20	2020-02-24	57,000	—	$0	0	SEC↗
GUGGENHIME ANDREW	CFO	D To issuer deriv	2020-02-20	2020-02-24	65,000	—	$0	0	SEC↗
GUGGENHIME ANDREW	CFO	D To issuer deriv	2020-02-20	2020-02-24	3,562	—	$0	0	SEC↗
GUGGENHIME ANDREW	CFO	D To issuer deriv	2020-02-20	2020-02-24	5,700	—	$0	0	SEC↗
GUGGENHIME ANDREW	CFO	D To issuer deriv	2020-02-20	2020-02-24	25,000	—	$0	0	SEC↗
GUGGENHIME ANDREW	CFO	D To issuer deriv	2020-02-20	2020-02-24	15,000	—	$0	0	SEC↗
Nunn Jason Raleigh	Director	D To issuer deriv	2020-02-20	2020-02-24	3,000	—	$0	0	SEC↗
Nunn Jason Raleigh	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
Nunn Jason Raleigh	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
Nunn Jason Raleigh	Director	D To issuer deriv	2020-02-20	2020-02-24	10,344	—	$0	0	SEC↗
Nunn Jason Raleigh	Director	D To issuer deriv	2020-02-20	2020-02-24	10,334	—	$0	0	SEC↗
Nunn Jason Raleigh	Director	D To issuer deriv	2020-02-20	2020-02-24	6,000	—	$0	0	SEC↗
ELI LILLY & Co	10% Owner	P Buy	2020-02-20	2020-02-20	40,926,025	$18.75	$767.36M	100	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	D To issuer	2020-02-20	2020-02-24	67,242	$18.75	$1.26M	0	SEC↗
Pena Luis C.	Chief Development Officer	D To issuer	2020-02-20	2020-02-24	18,233	$18.75	$341.9K	0	SEC↗
Cohen David E	Director	D To issuer	2020-02-20	2020-02-24	35,682	$18.75	$669.0K	0	SEC↗
Sebelius Kathleen	Director	D To issuer	2020-02-20	2020-02-24	6,000	$18.75	$112.5K	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	D To issuer	2020-02-20	2020-02-24	180,985	$18.75	$3.39M	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	D To issuer	2020-02-20	2020-02-24	49,963	$18.75	$936.8K	0	SEC↗
RINGO WILLIAM R	Director	D To issuer	2020-02-20	2020-02-24	6,000	$18.75	$112.5K	0	SEC↗
CRAVES FRED B	Director	D To issuer	2020-02-20	2020-02-24	6,000	$18.75	$112.5K	0	SEC↗
CRAVES FRED B	Director	D To issuer	2020-02-20	2020-02-24	3,441,075	$18.75	$64.52M	0	SEC↗
CRAVES FRED B	Director	D To issuer	2020-02-20	2020-02-24	30,000	$18.75	$562.5K	0	SEC↗
CRAVES FRED B	Director	D To issuer	2020-02-20	2020-02-24	65,572	$18.75	$1.23M	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	D To issuer	2020-02-20	2020-02-24	3,726	$18.75	$69.9K	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	D To issuer	2020-02-20	2020-02-24	16,206	$18.75	$303.9K	0	SEC↗
Horan Christopher	Chief Technical Ops Officer	D To issuer	2020-02-20	2020-02-24	21,400	$18.75	$401.3K	0	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	D To issuer	2020-02-20	2020-02-24	30,089	$18.75	$564.2K	0	SEC↗
Lyons-Williams Lori	Chief Commercial Officer	D To issuer	2020-02-20	2020-02-24	25,401	$18.75	$476.3K	0	SEC↗
Fust Matthew K	Director	D To issuer	2020-02-20	2020-02-24	5,051	$18.75	$94.7K	0	SEC↗
MCDADE MARK	Director	D To issuer	2020-02-20	2020-02-24	6,000	$18.75	$112.5K	0	SEC↗
GUGGENHIME ANDREW	CFO	D To issuer	2020-02-20	2020-02-24	41,951	$18.75	$786.6K	0	SEC↗
Nunn Jason Raleigh	Director	D To issuer	2020-02-20	2020-02-24	6,000	$18.75	$112.5K	0	SEC↗
BAUER EUGENE A	Chief Medical Officer	G Gift	2020-02-11	2020-02-24	12,924	—	$0	3,726	SEC↗
BAUER EUGENE A	Chief Medical Officer	G Gift	2020-02-11	2020-02-24	10,772	—	$0	16,206	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	G Gift	2020-02-05	2020-02-24	27,000	—	$0	49,963	SEC↗
Fust Matthew K	Director	S Sale	2019-12-24	2019-12-26	3,000	$15.00	$45.0K	5,051	SEC↗
Fust Matthew K	Director	S Sale	2019-12-12	2019-12-13	3,000	$12.00	$36.0K	8,051	SEC↗
Gilbert Halley E	Director	A Award deriv	2019-11-11	2019-11-13	20,000	—	$0	20,000	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	A Award deriv	2019-11-11	2019-11-13	28,000	—	$0	28,000	SEC↗
Aurora Daljit Singh	Chief Scientific Affairs Off	A Award deriv	2019-11-11	2019-11-13	6,000	—	$0	6,000	SEC↗
Fust Matthew K	Director	S Sale	2019-09-12	2019-09-16	6,000	$8.77	$52.6K	11,051	SEC↗
Pena Luis C.	Chief Development Officer	M Exercise deriv	2019-08-19	2019-08-19	3,576	—	$0	88,251	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	P Buy	2019-08-19	2019-08-19	23,419	$8.54	$200.0K	75,940	SEC↗
Pena Luis C.	Chief Development Officer	S Sale	2019-08-19	2019-08-19	23,419	$8.54	$200.0K	17,209	SEC↗
Pena Luis C.	Chief Development Officer	M Exercise	2019-08-19	2019-08-19	3,576	$0.99	$3.5K	40,628	SEC↗
GUGGENHIME ANDREW	CFO	M Exercise deriv	2019-08-15	2019-08-19	3,562	—	$0	0	SEC↗
GUGGENHIME ANDREW	CFO	M Exercise deriv	2019-08-15	2019-08-19	3,563	—	$0	3,562	SEC↗
GUGGENHIME ANDREW	CFO	M Exercise deriv	2019-08-15	2019-08-19	2,850	—	$0	5,700	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	M Exercise deriv	2019-08-15	2019-08-19	9,000	—	$0	9,000	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	M Exercise deriv	2019-08-15	2019-08-19	9,000	—	$0	0	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	M Exercise deriv	2019-08-15	2019-08-19	7,500	—	$0	15,000	SEC↗
BAUER EUGENE A	Chief Medical Officer	M Exercise deriv	2019-08-15	2019-08-19	2,850	—	$0	5,700	SEC↗
BAUER EUGENE A	Chief Medical Officer	M Exercise deriv	2019-08-15	2019-08-19	2,438	—	$0	2,437	SEC↗
BAUER EUGENE A	Chief Medical Officer	M Exercise deriv	2019-08-15	2019-08-19	2,625	—	$0	0	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	M Exercise deriv	2019-08-15	2019-08-19	1,407	—	$0	2,814	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	M Exercise deriv	2019-08-15	2019-08-19	1,050	—	$0	2,100	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	M Exercise deriv	2019-08-15	2019-08-19	938	—	$0	937	SEC↗
Griffith Christopher M.	Chief Business & Strategy Of	M Exercise deriv	2019-08-15	2019-08-19	1,078	—	$0	0	SEC↗
Lyons-Williams Lori	Chief Commercial Officer	M Exercise deriv	2019-08-15	2019-08-19	3,189	—	$0	6,378	SEC↗
Pena Luis C.	Chief Development Officer	M Exercise deriv	2019-08-15	2019-08-19	3,189	—	$0	6,378	SEC↗
Pena Luis C.	Chief Development Officer	M Exercise deriv	2019-08-15	2019-08-19	2,438	—	$0	2,437	SEC↗
Pena Luis C.	Chief Development Officer	M Exercise deriv	2019-08-15	2019-08-19	3,000	—	$0	0	SEC↗
GUGGENHIME ANDREW	CFO	F Tax w/h	2019-08-15	2019-08-19	986	$7.91	$7.8K	43,392	SEC↗
GUGGENHIME ANDREW	CFO	M Exercise	2019-08-15	2019-08-19	2,850	—	$0	37,253	SEC↗
GUGGENHIME ANDREW	CFO	M Exercise	2019-08-15	2019-08-19	3,563	—	$0	40,816	SEC↗
GUGGENHIME ANDREW	CFO	M Exercise	2019-08-15	2019-08-19	3,562	—	$0	44,378	SEC↗
GUGGENHIME ANDREW	CFO	F Tax w/h	2019-08-15	2019-08-19	1,233	$7.91	$9.8K	42,159	SEC↗
GUGGENHIME ANDREW	CFO	F Tax w/h	2019-08-15	2019-08-19	1,232	$7.91	$9.7K	40,927	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	M Exercise	2019-08-15	2019-08-19	9,000	—	$0	48,666	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	M Exercise	2019-08-15	2019-08-19	7,500	—	$0	65,166	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	M Exercise	2019-08-15	2019-08-19	9,000	—	$0	57,666	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	F Tax w/h	2019-08-15	2019-08-19	3,719	$7.91	$29.4K	52,521	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	F Tax w/h	2019-08-15	2019-08-19	4,463	$7.91	$35.3K	56,240	SEC↗
WIGGANS THOMAS G	CEO & Chairman of the Board	F Tax w/h	2019-08-15	2019-08-19	4,463	$7.91	$35.3K	60,703	SEC↗
BAUER EUGENE A	Chief Medical Officer	F Tax w/h	2019-08-15	2019-08-19	844	$7.91	$6.7K	17,223	SEC↗
BAUER EUGENE A	Chief Medical Officer	F Tax w/h	2019-08-15	2019-08-19	986	$7.91	$7.8K	15,329	SEC↗
BAUER EUGENE A	Chief Medical Officer	F Tax w/h	2019-08-15	2019-08-19	908	$7.91	$7.2K	16,315	SEC↗
BAUER EUGENE A	Chief Medical Officer	M Exercise	2019-08-15	2019-08-19	2,438	—	$0	12,592	SEC↗
BAUER EUGENE A	Chief Medical Officer	M Exercise	2019-08-15	2019-08-19	2,850	—	$0	15,442	SEC↗
BAUER EUGENE A	Chief Medical Officer	M Exercise	2019-08-15	2019-08-19	2,625	—	$0	18,067	SEC↗